Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 3 (2006), Issue 5 (May)

1. CT-MR image fusion for the management of skull base lesions.
   Otolaryngol Head Neck Surg, 134(5): 868-76. [Abstract] [Full-text]
2. Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas.
   Oncogene, 25(19): 2807-11. [Abstract] [Full-text]
3. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
   Oncogene, 25(19): 2795-800. [Abstract] [Full-text]
4. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
   Pediatr Blood Cancer, 47(1): 22-9. [Abstract] [Full-text]
5. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
   Pediatr Blood Cancer, 47(1): 42-50. [Abstract] [Full-text]
6. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
   Urology, 67(5): 1084.e15-7. [Abstract] [Full-text]
7. Genes associated with breast cancer metastatic to bone.
   J Clin Oncol, 24(15): 2261-7. [Abstract] [Full-text]
8. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
   J Orthop Res, 24(6): 1138-44. [Abstract] [Full-text]
9. Anticancer effects of zoledronic acid against human osteosarcoma cells.
   J Orthop Res, 24(6): 1145-52. [Abstract] [Full-text]
10. Expression of survivin and correlation with PCNA in osteosarcoma.
    J Surg Oncol, 93(7): 578-84. [Abstract] [Full-text]
11. Effect of interleukin-18 on metastasis of mouse osteosarcoma cells.
    Cancer Immunol Immunother, 55(9): 1151-8. [Abstract] [Full-text]

© 2004-2008 Bone Cancer Research Today. All Rights Reserved.